A detailed history of California State Teachers Retirement System transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 12,176 shares of XFOR stock, worth $4,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,176
Previous 12,176 -0.0%
Holding current value
$4,139
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.58 - $1.47 $241 - $612
-417 Reduced 3.31%
12,176 $7,000
Q1 2024

May 15, 2024

SELL
$0.72 - $1.46 $5,523 - $11,201
-7,672 Reduced 37.86%
12,593 $17,000
Q4 2023

Feb 13, 2024

SELL
$0.61 - $0.99 $4,210 - $6,832
-6,902 Reduced 25.41%
20,265 $17,000
Q3 2023

Nov 14, 2023

SELL
$1.03 - $2.02 $14,202 - $27,853
-13,789 Reduced 33.67%
27,167 $29,000
Q2 2023

Aug 21, 2023

BUY
$0.82 - $2.49 $33,583 - $101,980
40,956 New
40,956 $79,000
Q2 2021

Aug 16, 2021

SELL
$6.49 - $9.56 $160,179 - $235,950
-24,681 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$6.63 - $10.28 $7,558 - $11,719
1,140 Added 4.84%
24,681 $213,000
Q3 2020

Nov 17, 2020

BUY
$6.09 - $9.15 $584 - $878
96 Added 0.41%
23,541 $159,000
Q1 2020

May 13, 2020

BUY
$6.03 - $11.01 $32,670 - $59,652
5,418 Added 30.05%
23,445 $234,000
Q4 2019

Feb 14, 2020

SELL
$9.93 - $14.33 $4,647 - $6,706
-468 Reduced 2.53%
18,027 $193,000
Q3 2019

Nov 15, 2019

BUY
$11.06 - $15.75 $85,681 - $122,015
7,747 Added 72.08%
18,495 $235,000
Q2 2019

Aug 14, 2019

BUY
$12.57 - $21.67 $120,282 - $207,360
9,569 Added 811.62%
10,748 $161,000
Q1 2019

May 09, 2019

BUY
$15.19 - $22.98 $17,909 - $27,093
1,179 New
1,179 $21,000

Others Institutions Holding XFOR

About X4 Pharmaceuticals, Inc


  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.